Genshaft, Alex S
Ziegler, Carly G. K. http://orcid.org/0000-0002-8279-7150
Tzouanas, Constantine N. http://orcid.org/0000-0002-7536-1156
Mead, Benjamin E. http://orcid.org/0000-0001-7258-7777
Jaeger, Alex M.
Navia, Andrew W.
King, Ryan P.
Mana, Miyeko D.
Huang, Siyi
Mitsialis, Vanessa http://orcid.org/0000-0002-1186-3616
Snapper, Scott B. http://orcid.org/0000-0003-0267-4247
Yilmaz, Ă–mer H. http://orcid.org/0000-0002-7577-4612
Jacks, Tyler http://orcid.org/0000-0001-5785-8911
Van Humbeck, Jeffrey F. http://orcid.org/0000-0002-8910-4820
Shalek, Alex K. http://orcid.org/0000-0001-5670-8778
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753)
Hertz Foundation
National Science Foundation (1122374)
Damon Runyon Cancer Research Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5K99CA241072-02)
Howard Hughes Medical Institute
Ragon Institute of MGH, MIT and Harvard
U.S. Department of Health & Human Services | National Institutes of Health (1DP2GM119419, 2RM1HG006193, U2CCA23319501)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Searle Scholars Program Beckman Young Investigator Program Pew-Stewart Scholars Program for Cancer Research Sloan Fellowship in Chemistry
Article History
Received: 31 March 2021
Accepted: 26 July 2021
First Online: 17 August 2021
Change Date: 3 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-25672-7
Competing interests
: T.J. is a member of the Board of Directors of Amgen and Thermo Fisher Scientific and a co-Founder of Dragonfly Therapeutics and T2 Biosystems. T.J. serves on the Scientific Advisory Board of Dragonfly Therapeutics, SQZ Biotech, and Skyhawk Therapeutics. T.J. is also President of Break Through Cancer. His laboratory currently receives funding from Johnson & Johnson and Lustgarten Foundation, but these funds did not support the research described in this manuscript. A.K.S. has received compensation for consulting and scientific advisory board membership from Merck, Honeycomb Biotechnologies, Cellarity, Repertoire Immune Medicines, Hovione, Third Rock Ventures, Ochre Bio, and Dahlia Biosciences unrelated to this work. A.S.G., C.G.K.Z., A.K.S., and J.F.V.H. are co-inventors on a provisional patent application filed by the Broad Institute (U.S. Patent Application Nos. 16/494,911 and 62/473,222) relating to the methods and results described in this manuscript. The remaining authors declare no competing interests.